BIG1 Stock Overview
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Bio-Gate AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.00 |
| 52 Week High | €2.22 |
| 52 Week Low | €0.57 |
| Beta | 0.22 |
| 1 Month Change | -13.04% |
| 3 Month Change | 5.26% |
| 1 Year Change | -54.55% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIG1 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -4.8% | -1.4% | -2.0% |
| 1Y | -54.5% | -1.2% | -0.3% |
Return vs Industry: BIG1 underperformed the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: BIG1 underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| BIG1 volatility | |
|---|---|
| BIG1 Average Weekly Movement | 10.8% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BIG1's share price has been volatile over the past 3 months.
Volatility Over Time: BIG1's weekly volatility has decreased from 19% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 38 | Marc Lloret-Grau | www.bio-gate.de |
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives.
Bio-Gate AG Fundamentals Summary
| BIG1 fundamental statistics | |
|---|---|
| Market cap | €9.24m |
| Earnings (TTM) | -€1.45m |
| Revenue (TTM) | €6.68m |
1.4x
P/S Ratio-6.4x
P/E RatioIs BIG1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIG1 income statement (TTM) | |
|---|---|
| Revenue | €6.68m |
| Cost of Revenue | €2.37m |
| Gross Profit | €4.31m |
| Other Expenses | €5.75m |
| Earnings | -€1.45m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 64.50% |
| Net Profit Margin | -21.67% |
| Debt/Equity Ratio | 11.6% |
How did BIG1 perform over the long term?
See historical performance and comparison